- Home
- KIRK vs GOVX Comparison
KIRK vs GOVX Comparison
Compare KIRK & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIRK
- GOVX
- Stock Information
- Founded
- KIRK 1966
- GOVX 2001
- Country
- KIRK United States
- GOVX United States
- Employees
- KIRK N/A
- GOVX N/A
- Industry
- KIRK Diversified Commercial Services
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- KIRK Miscellaneous
- GOVX Health Care
- Exchange
- KIRK Nasdaq
- GOVX Nasdaq
- Market Cap
- KIRK 20.2M
- GOVX 19.5M
- IPO Year
- KIRK 2002
- GOVX N/A
- Fundamental
- Price
- KIRK $1.46
- GOVX $1.67
- Analyst Decision
- KIRK Buy
- GOVX Strong Buy
- Analyst Count
- KIRK 2
- GOVX 5
- Target Price
- KIRK $4.50
- GOVX $14.20
- AVG Volume (30 Days)
- KIRK 203.3K
- GOVX 569.4K
- Earning Date
- KIRK 03-20-2025
- GOVX 03-03-2025
- Dividend Yield
- KIRK N/A
- GOVX N/A
- EPS Growth
- KIRK N/A
- GOVX N/A
- EPS
- KIRK N/A
- GOVX N/A
- Revenue
- KIRK $458,411,000.00
- GOVX $3,090,161.00
- Revenue This Year
- KIRK N/A
- GOVX N/A
- Revenue Next Year
- KIRK $0.37
- GOVX $150.51
- P/E Ratio
- KIRK N/A
- GOVX N/A
- Revenue Growth
- KIRK N/A
- GOVX N/A
- 52 Week Low
- KIRK $1.39
- GOVX $1.09
- 52 Week High
- KIRK $3.00
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- KIRK 37.18
- GOVX 37.32
- Support Level
- KIRK $1.51
- GOVX $1.50
- Resistance Level
- KIRK $1.58
- GOVX $1.79
- Average True Range (ATR)
- KIRK 0.07
- GOVX 0.13
- MACD
- KIRK -0.00
- GOVX 0.01
- Stochastic Oscillator
- KIRK 0.00
- GOVX 29.82
About KIRK Kirkland's Inc. COMMONSTOCK
Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.